These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 3942400
1. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay]. Kimura Y, Toki H, Okabe K, Fujii M, Tamai M. Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400 [Abstract] [Full Text] [Related]
2. [Effect of intravenous treatment with OK-432 on the bone marrow in patients with lung cancer]. Fujii M, Ishikawa M, Toki H. Gan No Rinsho; 1984 Mar; 30(3):230-2. PubMed ID: 6325756 [Abstract] [Full Text] [Related]
3. [Adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer]. Kikkawa N, Sasai H, Kawahara T. Gan To Kagaku Ryoho; 1984 Oct; 11(10):2163-9. PubMed ID: 6486832 [Abstract] [Full Text] [Related]
4. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity]. Hosoi J, Wakasugi H, Miyata M, Minato N, Imai M. Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):2044-55. PubMed ID: 7169577 [No Abstract] [Full Text] [Related]
5. [Effect of selective intra-arterial infusion of OK-432 against renal cell cancers]. Fujioka T, Tanji S, Koike H, Kumagai K, Suzuki K, Aoki H, Banya Y, Kubo T, Ohhori T. Hinyokika Kiyo; 1987 Jun 20; 33(6):832-7. PubMed ID: 3673835 [Abstract] [Full Text] [Related]
6. [The clinical value of long-term administration of OK-432 in head and neck cancer]. Mitarai K, Tsukuda M, Tamamushi N, Mochimastu I, Kubota A, Sawaki S. Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 1):945-50. PubMed ID: 3963858 [Abstract] [Full Text] [Related]
7. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)]. Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S. Nihon Gan Chiryo Gakkai Shi; 1990 May 20; 25(5):997-1012. PubMed ID: 2202770 [Abstract] [Full Text] [Related]
8. [Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432]. Nakarai I, Rikitake H, Koga T, Hayashi A, Harada Y, Takamoto M, Ishibashi T, Shinoda A, Sagawa K. Gan To Kagaku Ryoho; 1987 Nov 20; 14(11):3050-7. PubMed ID: 2823723 [Abstract] [Full Text] [Related]
9. [Production of a cytotoxic factor into malignant pleural fluid by OK-423, a streptococcal preparation--kinetic analysis]. Yoshinaga T, Nomura H, Nishimura H, Tomino S, Kawakita M, Takatsuki K, Fujimoto K, Etou Y, Nakaji T, Kiyama T. Gan To Kagaku Ryoho; 1986 Aug 20; 13(8):2675-7. PubMed ID: 3740864 [No Abstract] [Full Text] [Related]
10. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions. Tanaka T, Kaneko Y, Haba F, Katsuta S, Tsutsui K, Tamaki S, Chen DR, Suzuki S, Ueda R, Yamamoto A. J Clin Lab Immunol; 1989 Feb 20; 28(2):91-6. PubMed ID: 2787407 [Abstract] [Full Text] [Related]
11. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432]. Komatsu K, Nakamura W. C R Seances Soc Biol Fil; 1986 Feb 20; 180(1):117-20. PubMed ID: 2943364 [Abstract] [Full Text] [Related]
12. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents. Kaneto E, Sasaki H, Tamura I, Kurimura O, Kurimura T. Biken J; 1983 Jun 20; 26(2):99-102. PubMed ID: 6318725 [Abstract] [Full Text] [Related]
13. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS]. Katada H, Nishikawa K, Yoneda T, Kitamura H, Nakajima A, Mikami R. Gan To Kagaku Ryoho; 1987 Jan 20; 14(1):61-70. PubMed ID: 3026256 [Abstract] [Full Text] [Related]
14. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)]. Mukai M, Ando K, Koike S. Gan To Kagaku Ryoho; 1988 Apr 20; 15(4 Pt 1):631-5. PubMed ID: 3355184 [Abstract] [Full Text] [Related]
15. Interleukin-1 inducing activity of a streptococcal preparation OK-432 and its fractions by human monocytes. Katsuta S, Kaneko Y, Tsutsui K, Tamaki S, Ibata H, Chen DR, Suzuki S, Natsuume-Sakai S, Yamamoto A. J Clin Lab Immunol; 1989 Mar 20; 28(3):129-36. PubMed ID: 2661826 [Abstract] [Full Text] [Related]
16. [Combination therapy of large amount of carboquone and OK-432 for unresectable lung cancer]. Nakarai I, Honda T, Jinnai S, Kita T, Shinoda A. Gan To Kagaku Ryoho; 1982 Jul 20; 9(6):1006-11. PubMed ID: 7184436 [Abstract] [Full Text] [Related]
17. [Organ distribution of 99m technetium-labeled OK-432 following intravenous administration in man]. Toki H, Ishikawa M, Fujii M, Yumoto Y, Ishimitsu T. Gan To Kagaku Ryoho; 1982 Dec 20; 9(12):2201-6. PubMed ID: 7184393 [Abstract] [Full Text] [Related]
18. [Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor]. Fujioka T, Shiraishi M, Tanji S, Koike H, Suzuki K, Kumagai K, Aoki H, Sakuma Y, Ohhori T, Kubo T. Hinyokika Kiyo; 1989 Feb 20; 35(2):253-7. PubMed ID: 2735236 [Abstract] [Full Text] [Related]
19. [The effect of OK-432 in the treatment of primary lung cancer]. Kishimoto T, Okada K. Gan To Kagaku Ryoho; 1987 Apr 20; 14(4):1051-6. PubMed ID: 3494430 [Abstract] [Full Text] [Related]
20. [Clinical investigation of intratumoral OK-432 administration]. Shimada K, Tabuse K, Kono N, Katsumi M, Yamamoto H, Yamamoto Y, Endo A. Gan To Kagaku Ryoho; 1983 Aug 20; 10(8):1844-9. PubMed ID: 6882008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]